We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GAO Criticizes FDA for Allowing Momenta Scientist to Assist Agency
GAO Criticizes FDA for Allowing Momenta Scientist to Assist Agency
November 12, 2010
The Government Accountability Office (GAO) is criticizing the FDA for allowing a scientist from Momenta Pharmaceuticals to voluntarily assist the agency during its handling of the tainted heparin crisis in 2008, despite having an application for generic Lovenox still pending with the agency.